-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
ArriVent BioPharma, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from 2024 to Q1 2025.
- ArriVent BioPharma, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2025 was $36.8M.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, Annual (USD)